Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients

Launched by CHANG GUNG MEMORIAL HOSPITAL · Oct 25, 2018

Keywords

ClinConnect Summary

Study subject:

Inclusion criteria 1. Patients with clinical stage 1 to 3a non-small lung cancer 2. Patients with a resectable suspicious pulmonary lesion which is difficult for pre-operation tissue prove or refused for pre-operation biopsy 3. Received curative intended tumor resection Exclusion criteria

1. Small cell lung cancer component which identified in pathology
2. Patients who presented as stage IIIb or IV
3. Not received curative intended surgery due to multi-comorbidities
4. Patients who presented in tumor seeding or positive resection in pathology confirmation
5. Patients who re...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Non-small cell lung cancer patients with stage I to III
• • 2. Patients with resectable suspicious pulmonary malignant lesion
• • 1. no pre-operation diagnosis ( patients refused biopsy or difficult for biopsy)
• • 2. image survey showed clinical stage I to III
• Exclusion Criteria:
• • 1. Final pathology coexisted with small cell lung cancer component
• • 2. Patients who presented as stage IIIb or IV.
• • 3. Not received curative intended surgery due to multi-comorbidities.
• • 4. Patients who presented in tumor seeding or positive resection in the final pathology
• • 5. Patients who received neoadjuvant therapy.